Navigation Links
Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Date:7/16/2009

SAN DIEGO, July 16 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Sumavel DosePro (sumatriptan injection) needle-free delivery system to treat acute migraine, with or without aura, and cluster headache. Sumavel DosePro is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for some patients.

"In my 28 years treating migraine patients, a consistent challenge has been delivering fast relief in a patient acceptable form," said Roger K. Cady, M.D., director of the Headache Care Center in Springfield, Mo. "Sumavel DosePro will be a welcome treatment option because it combines key benefits - the rapid efficacy of subcutaneous sumatriptan and a simple to use needle-free delivery system."

Triptans, the most commonly prescribed class of drugs for the treatment of migraine, are a $3.3 billion market in the U.S. (Source: Wolters Kluwer Health, Source(R) Pharmaceutical Audit Suite (PHAST). Based on AWP for U.S. retail prescriptions of drugs in the triptan market, May 2008 --April 2009.) According to the National Headache Foundation, acute migraines affect nearly 30 million Americans. Tablets are a treatment option for some migraine sufferers, but not all patients are satisfied with tablet therapy. Fast-acting, non-oral options are needed particularly for those who experience migraine episodes associated with sudden onset, waking, nausea or vomiting.

The FDA approval of Sumavel DosePro is based on extensive efficacy and safety data from original filings for needle-based sumatriptan injection (IMITREX((R))), in addition to clinical studies conducted by Zogenix on bioequivalence, usability and saf
'/>"/>

SOURCE Zogenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM)
2. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
3. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
4. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
5. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
6. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
7. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
8. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
9. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
10. Clexane(R)/Lovenox(R) Approved in Japan
11. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprest...ion,sleadingonlinejobboardandcareerssiteforlifesci...iversityarenowmembersofthejobboard,joining28otherm...oard, www.biocareercenter.com ,isonlyforpost-gradu...ciencecareersitesontheInternet,BioCareerCenteristh...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxy...on(SFDA)hasapprovedthe,investigationalnewdrugappli...ovativeinsulinformulationtotreatdiabetes.ThisIND,a...alstudy. , Diabetesisadisordercharacteristico...nsofdiabetesoftenresultinseveremicro-and,macro-vas...
(Date:11/24/2009)... TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-F...lottoCapitalInc.,aleadingproviderofadvancedlasersy...ityclinicmarkets,todayreportedoperationalandfinanc... , ,Q32009Highlights,-Revenuewas$1.46millioncomp...66.3percentcomparedwith66.1percentinQ3,2008,-Netlo...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
... METTLER TOLEDO invites you to register for our...Chemists and Chemical Engineers. Visit our Webina...inars, as well as a listing of over sixty On-Deman...binars are accessible 24 hours a day, 365 days a y...B) February 14, 2009 -- Each free webinar offers ...
...ing technology provided by GeneSeek Inc. , , LINC... company, will be used for medical-grade source pi...ct, a Minnesota non-profit organization providing ...es. With this technology, GeneSeek, a certified Il...actual high-throughput genotyping, will help Sprin...
.... 13 InterMune, Inc. (Nasdaq: ITMN ) today anno...ng of 3,500,000 shares of its common stock. The l...k on the NASDAQ Global Select Market on February 1...lose on or about February 19, 2009, subject to cus...being sold by the company. , , UBS Investment Ban...
Other Biology Technology:Free Webinars in Chemistry and Chemical Engineering 2Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 2Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 3InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock 2
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
(Date:11/24/2009)...merican College of Medical Toxicology (ACMT) have ...ion of the Journal of Medical Toxicology (JMT), ...ch 2010. It was previously published by the Unive...Medical Toxicology , an international, peer-review...and practice of medical toxicology. The quarterly...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 1Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 2Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association Broward County 26apos 3Bs 2010 Heart Ball Heart Society 60758 3New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 1New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 2New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 60755 3Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 1Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 2
...trations and Issues Voter Rolls and ...KA, Bangladesh, Nov. 26 ,BIO-key International, In...based biometric identification and wireless public... in both prepackaged and customized software,solut...an exclusive,contract for the biometric-based cred...
...ping-out ceremony for the experimental hall of PET...ay light in Hamburg. On occasion of the structural...ter Dr. Annette Schavan and Hamburgs First Mayor O... DESY. Its new light source PETRA III is due to be... the way to a world leading centre for interdiscip...
...research program by Dr. Dariusz Malinowski has him...an alternative to winter wheat pastures. , But th... many parts of the nation, said Malinowski, a Texa...t in Vernon. They are from the Mediterranean Basin...imate is changing here, he said. Its been getting ...
Other Biology News:BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 2BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 3BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh 4Brilliant perspectives 2Brilliant perspectives 3Summer-dormant tall fescue grass shows promise for pasture improvements 2Summer-dormant tall fescue grass shows promise for pasture improvements 3
Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems
Mouse Anti-G9a / EHMT2 Monoclonal Antibody, Unconjugated, Clone A8620A from R&D Systems
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Anti-Mouse GDF-8 Polyclonal Antibodies, from R&D Systems
Biology Products: